McKesson's earnings call conveyed a strong performance this quarter with substantial revenue growth and successful strategic acquisitions. Despite some challenges, such as the impact from Rite Aid's bankruptcy and the exit from European operations, the company showed robust operational execution and raised its full-year guidance, indicating a positive outlook.

Company Guidance -

Q2 2026

During McKesson's First Quarter Fiscal 2026 Earnings Conference Call, the company reported record consolidated revenues of $97.8 billion, which marked a 23% increase over the prior year. Adjusted operating profit rose by 9% to $1.4 billion, with three segments achieving double-digit growth in adjusted operating profit. The company raised its full-year guidance, projecting earnings per diluted share to range between $37.10 and $37.90, up from the previous range of $36.90 to $37.70. The U.S. Pharmaceutical segment saw a 25% revenue increase to $90 billion, supported by increased prescription volumes and specialty products distribution. Meanwhile, the Prescription Technology Solutions segment experienced 16% revenue growth, driven by demand for access and affordability solutions. McKesson's strategic acquisitions, such as PRISM Vision and Core Ventures, are anticipated to contribute 6% to 7% to the fiscal 2026 U.S. Pharmaceutical segment's operating profit growth. The company's financial outlook for the year includes revenue growth of 11% to 15% and operating profit growth of 9% to 13%, with an effective tax rate ranging from 17% to 19%.

Record-Breaking Revenue Growth

McKesson reported record consolidated revenues of $97.8 billion, an increase of 23% over the prior year.

Increased Full-Year Guidance

McKesson raised its full year guidance to $37.10 to $37.90, up from the previous range of $36.90 to $37.70, reflecting strong performance and confidence in continued growth.

Successful Strategic Acquisitions

McKesson completed acquisitions of controlling interests in Core Ventures and PRISM Vision, enhancing their oncology and ophthalmology platforms.

Strong Segment Performance

Three segments delivered double-digit growth in adjusted operating profit. Prescription Technology Solutions saw a 21% increase in operating profit.

McKesson (MCK) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

MCK Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 04, 2025	2026 (Q2)	8.85 / -	7.07	―	―	―
Aug 06, 2025	2026 (Q1)	8.14 / 8.26	7.88	4.82% (+0.38)
May 08, 2025	2025 (Q4)	9.83 / 10.12	6.18	63.75% (+3.94)
Feb 05, 2025	2025 (Q3)	7.99 / 8.03	7.74	3.75% (+0.29)
Nov 06, 2024	2025 (Q2)	6.88 / 7.07	6.23	13.48% (+0.84)
Aug 07, 2024	2025 (Q1)	7.21 / 7.88	7.27	8.39% (+0.61)
May 07, 2024	2024 (Q4)	6.36 / 6.18	7.19	-14.05% (-1.01)
Feb 07, 2024	2024 (Q3)	7.04 / 7.74	6.9	12.17% (+0.84)
Nov 01, 2023	2024 (Q2)	6.15 / 6.23	6.06	2.81% (+0.17)
Aug 02, 2023	2024 (Q1)	5.87 / 7.27	5.83	24.70% (+1.44)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

MCK Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 06, 2025	$703.76	$663.25	-5.76%
May 08, 2025	$689.57	$692.78	+0.47%
Feb 05, 2025	$605.63	$598.49	-1.18%
Nov 06, 2024	$547.54	$605.55	+10.59%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Mckesson Corp. (MCK) report earnings?

Mckesson Corp. (MCK) is schdueled to report earning on Nov 04, 2025, Before Open (Confirmed).

What is Mckesson Corp. (MCK) earnings time?

Mckesson Corp. (MCK) earnings time is at Nov 04, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is MCK EPS forecast?

MCK EPS forecast for the fiscal quarter 2026 (Q2) is 8.85.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing